Anzeige
Mehr »
Donnerstag, 25.09.2025 - Börsentäglich über 12.000 News
Geheime Börsenchance: Ist das die bedeutendste Kupferentdeckung Kanadas?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0M103 | ISIN: BE0003874915 | Ticker-Symbol: 4A5
Tradegate
25.09.25 | 12:27
19,520 Euro
-0,41 % -0,080
Branche
Gesundheitswesen
Aktienmarkt
BEL Mid
AMX
1-Jahres-Chart
FAGRON NV Chart 1 Jahr
5-Tage-Chart
FAGRON NV 5-Tage-Chart
RealtimeGeldBriefZeit
19,54019,56012:41
19,54019,56012:38

Aktuelle News zur FAGRON Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07:06Fagron NV: Fagron announces the acquisition of UCP in North America and FDA inspection update44Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 25 September 2025 - 7:00 AM CET Fagron announces the acquisition of UCP in North America and FDA inspection...
► Artikel lesen
05.09.Fagron NV: Disclosure of notification received from Mawer14
31.07.Fagron NV: Fagron delivers strong performance with 11% topline growth and 12% increase in REBITDA for H1 2025370Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 31 July 2025 - 7:00 AM CET Fagron delivers strong performance with 11% topline growth and 12% increase in...
► Artikel lesen
18.07.Fagron NV: Disclosure of notification received from Alychlo8
06.06.Fagron NV: Fagron increases share capital through exercise subscription rights452Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 June 2025 - 7PM CET Fagron increases share capital through exercise subscription rights Fagron announces that as a result of...
► Artikel lesen
FAGRON Aktie jetzt für 0€ handeln
12.05.Fagron NV: Fagron shareholders approve all voting items AGM1
16.04.Berenberg maintains Buy rating, EUR22.70 target on Fagron shares2
11.04.Fagron empfiehlt Suspensionsgrundlage: Azithromycin: Lieferengpass durch Rezeptur abfedern7
11.04.Fagron NV: Fagron publishes agenda for 2025 annual shareholders meeting1
10.04.Fagron NV: Fagron to present its upgraded growth strategy and mid-term financial targets at its Capital Markets Day 20252
10.04.Fagron NV: Record first-quarter revenue of €239 million, reflecting 14% topline growth653Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 10 April 2025 - 7:00 AM CET Record first-quarter revenue of €239 million, reflecting 14% topline growth Fagron...
► Artikel lesen
20.02.Fagron NV: Fagron delivers exceptional performance with 14% topline growth and 17% increase in REBITDA for FY 2024683Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 20 February 2025 - 7AM CET Fagron delivers exceptional performance with 14% topline growth and 17% increase...
► Artikel lesen
04.02.Fagron NV: Fagron solidifies its leadership position with the acquisition of Guinama in Spain740Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 4 Feb 2025 - 7AM CET Fagron solidifies its leadership position with the acquisition of Guinama in Spain Fagron, the leading global...
► Artikel lesen
07.01.Fagron NV: Fagron strengthens its market positioning with the acquisitions of CareFirst in North America and Injeplast in Brazil573Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 7 Jan 2025 - 7AM CET Fagron strengthens its market positioning with the acquisitions of CareFirst in North America and Injeplast...
► Artikel lesen
23.12.24Fagron NV: Fagron updates on FDA communication regarding the June 2024 inspection at Wichita724Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 23 Dec 2024 - 7AM CET Fagron updates on FDA communication regarding the June 2024 inspection at Wichita Following...
► Artikel lesen
10.10.24Fagron NV: Fagron reports outstanding third quarter 2024 performance with 12.1% revenue growth and reaffirms full-year outlook786Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 10 October 2024 - 7:00 AM CET Fagron reports outstanding third quarter 2024 performance with 12.1% revenue...
► Artikel lesen
08.10.24Fagron NV: Disclosure of notification received from AOC Pharma S.à r.l.700Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 8 October 2024 - 9:00 PM CET Disclosure of notification received from AOC Pharma S.à r.l. Pursuant to the Belgian law of 2 May...
► Artikel lesen
17 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1